Leading Executives in Health Care
Noubar Afeyan
Founder & Chief Executive Officer, Flagship Pioneering
Flagship’s founder/CEO and Moderna’s co‑founder/chair, he pioneered the “bioplatform” venture model that has launched 100+ life‑science companies with dozens of drugs in development.
Peter J. Arduini
President & Chief Executive Officer, GE HealthCare
Veteran med‑tech operator leading GE HealthCare’s next phase as a stand‑alone imaging, ultrasound and patient‑care technology leader.
Stéphane Bancel
Chief Executive Officer, Moderna
Long‑time CEO who scaled mRNA from concept to global impact and is steering Moderna’s respiratory, oncology and rare‑disease pipelines beyond COVID‑19.
Robert A. Bradway
Chairman & Chief Executive Officer, Amgen
One of biotech’s longest‑tenured chiefs, he has guided Amgen’s growth and portfolio diversification since 2012.
Albert Bourla
Chairman & Chief Executive Officer, Pfizer
Chairman/CEO focused on breakthrough science and scale, with a public presence engaging stakeholders on R&D and access.
Website (bio) | X / Twitter | LinkedIn
Robert M. Davis
Chairman & Chief Executive Officer, Merck & Co.
Became CEO in 2021 and chair in 2022; leading Merck’s next chapter while sustaining innovation across oncology, vaccines and specialty care.
Website (bio) | Media contacts
Joaquin Duato
Chairman & Chief Executive Officer, Johnson & Johnson
Chairman/CEO steering J&J’s sharpened focus on innovative medicines and MedTech following the consumer health separation.
Judy Faulkner
Founder & Chief Executive Officer, Epic Systems
Software pioneer who founded Epic in 1979 and built it into the dominant U.S. electronic health record platform used by leading health systems.
Website (company) | Newsroom feature
Robert B. Ford
Chairman & Chief Executive Officer, Abbott
Chairman/CEO leading a diversified med‑tech and diagnostics portfolio spanning glucose monitoring, cardiovascular, and rapid testing.
Stephen J. Hemsley
Chairman & Chief Executive Officer, UnitedHealth Group
Industry veteran who returned to the CEO role in May 2025 to stabilize and reposition the nation’s largest health‑care enterprise.
Press release | Media resources
J. David Joyner
President & Chief Executive Officer, CVS Health
Elevated to CEO in October 2024; leading CVS Health’s integrated model across Aetna (benefits), Caremark (PBM) and a 9,000‑location retail footprint.
Website (officers) | Media contacts
Reshma Kewalramani, M.D.
President & Chief Executive Officer, Vertex Pharmaceuticals
Physician‑scientist who became CEO in 2020 and expanded Vertex beyond cystic fibrosis into gene‑editing and other serious‑disease programs.
Press release (CEO) | News (2025)
Michael F. Mahoney
Chairman & Chief Executive Officer, Boston Scientific
Chair/CEO who has grown Boston Scientific into a top‑tier med‑tech innovator serving tens of millions of patients annually.
Geoff Martha
Chairman & Chief Executive Officer, Medtronic
Chair/CEO guiding one of the world’s largest health‑technology companies; recently engaged shareholders on strategy and portfolio focus.
Robert A. Michael
Chairman & Chief Executive Officer, AbbVie
Long‑time AbbVie operator who became CEO in 2024 and later chair, steering post‑Humira growth with immunology and oncology assets.
Bernd Montag, Ph.D.
Chief Executive Officer, Siemens Healthineers
CEO since 2015 who led the company’s public listing and global scale‑up across imaging, diagnostics and cancer care.
Daniel O’Day
Chairman & Chief Executive Officer, Gilead Sciences
Chairman/CEO since 2019, advancing antivirals and oncology while integrating cell‑therapy leader Kite.
David A. Ricks
Chair & Chief Executive Officer, Eli Lilly and Company
Chair/CEO credited with Lilly’s breakthrough GLP‑1 franchise and record R&D output, making the company a global value leader in pharma.
Thomas Schinecker, Ph.D.
Chief Executive Officer, Roche Group, Roche
Former Diagnostics chief who became Group CEO in 2023, uniting pharma and diagnostics strengths to drive personalized medicine.
Pascal Soriot
Executive Director & Chief Executive Officer, AstraZeneca
One of pharma’s longest‑serving CEOs, he has revitalized AstraZeneca’s pipeline and growth, particularly in oncology and biopharma.
Related Topics
Further Reading
Was this page helpful? We'd love your feedback — please email us at feedback@dealstream.com.